109
Views
1
CrossRef citations to date
0
Altmetric
Review

Nutritional interventions to reduce cardiovascular risk factors: an Iranian perspective

&
Pages 51-60 | Published online: 28 Apr 2015

References

  • Amine E, Baba N, Belhadj M, et al. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Geneva: World Health Organization; 2002.
  • Kelly BB, Fuster V. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, DC: National Academies Press; 2010.
  • Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005;162(8):764–773.
  • Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9):1101–1107.
  • Hu FB. Globalization of food patterns and cardiovascular disease risk. Circulation. 2008;118(19):1913–1914.
  • Dangour AD, Uauy R. Nutrition challenges for the twenty-first century. Br J Nutr. 2006;96(S1):S2–S7.
  • Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr. 2002;5(1a):149–155.
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2095–2128.
  • Sarraf-Zadegan N, Sadri G, Malek Afzali H, et al. Isfahan Healthy Heart Program: a comprehensive integrated community-based program for cardiovascular disease prevention and control. Acta Cardiol. 2003;58(4):309–320.
  • Rabiei K, Kelishadi R, Sarrafzadegan N, et al. Isfahan Healthy Heart Program: evaluation of comprehensive, community-based interventions for non-communicable disease prevention. Prev Contr. 2006;2(2):73–84.
  • Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, et al. Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull World Health Organ. 2009;87(1):39–50.
  • Mohammadifard N, Kelishadi R, Safavi M, et al. Effect of a community-based intervention on nutritional behaviour in a developing country setting: the Isfahan Healthy Heart Programme. Public Health Nutr. 2009;12(09):1422–1430.
  • Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Präventivmed. 2002;47(6):408–426.
  • Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R. Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr. 2006;95(12):1625–1634.
  • Kelishadi R, Gheiratmand R, Ardalan G, et al; CASPIAN Study Group. Association of anthropometric indices with cardiovascular disease risk factors among children and adolescents: CASPIAN Study. Int J Cardiol. 2007;117(3):340–348.
  • Vosoogh Moghaddam A, Damari B, Alikhani S, et al. Health in the 5th 5-years development plan of Iran: main challenges, general policies and strategies. Iran J Public Health. 2013;42(Suppl 1):42.
  • World Health Organization. World Health Statistics 2014. Geneva, Switzerland: World Health Organization; 2014:120.
  • Astrup A. Dietary fat is a major player in obesity – but not the only one. Obes Rev. 2002;3(2):57–58.
  • Vadiveloo M, Scott M, Quatromoni P, Jacques P, Parekh N. Trends in dietary fat and high-fat food intakes from 1991 to 2008 in the Framingham Heart Study participants. Br J Nutr. 2014;111(4):724–734.
  • Kelishadi R, Pour MH, Zadegan NS, et al. Dietary fat intake and lipid profiles of Iranian adolescents: Isfahan Healthy Heart Program – heart health promotion from childhood. Prev Med. 2004;39(4):760–766.
  • Mozaffarian D, Abdollahi M, Campos H, Houshiarrad A, Willett W. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr. 2007;61(8):1004–1010.
  • Esmaillzadeh A, Azadbakht L. Food intake patterns may explain the high prevalence of cardiovascular risk factors among Iranian women. J Nutr. 2008;138(8):1469–1475.
  • Lichtenstein AH, Erkkilä AT, Lamarche BT, Schwab US, Jalbert SM, Ausman LM. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis. 2003;171(1):97–107.
  • Amani R, Noorizadeh M, Rahmanian S, Afzali N, Haghighizadeh MH. Nutritional related cardiovascular risk factors in patients with coronary artery disease in IRAN: a case-control study. Nutr J. 2010; 9(70):21184687.
  • Mohammadifard N, Toghianifar N, Sajjadi F, et al. Improvement of dietary oil consumption following a community trial in a developing country: the role of translational research in health promotion. ARYA Atheroscler. 2013;9(1):29.
  • Peymani P, Joulaie H, Zamiri N, et al. Iran’s experience on reduction of trans-fatty acid content in edible oils. Middle East J Sci Res. 2012;11(9):1207–1211.
  • Lichtenstein AH. Dietary trans fatty acids and cardiovascular disease risk: past and present. Curr Atheroscler Rep. 2014;16(8):1–7.
  • Menaa F, Menaa A, Menaa B, Tréton J. Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France. Eur J Nutr. 2013;52(4):1289–1302.
  • Estruch R, Ros E, Salas-Salvadó J, et al; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–1290.
  • Jafari M, Kadivar M, Keramat J. Detection of adulteration in Iranian olive oils using instrumental (GC, NMR, DSC) methods. J Am Oil Chem Soc. 2009;86(2):103–110.
  • Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010;29(Suppl 3):289S–301S.
  • Amani R, Boustani F. Prevalence of obesity and dietary practices in Jondi-Shapour University female personnel, Ahvaz, Iran. Pak J Med Sci. 2008;24(5):748–752.
  • He FJ, MacGregor GA. Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol. 2007;22(4):298–305.
  • Khaw KT, Bingham S, Welch A, et al. Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr. 2004;80(5):1397–1403.
  • Meneton P, Jeunemaitre X, de Wardener HE, Macgregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85(2):679–715.
  • Naghavi M, Pourmalek F, Shahraz S, Jafari N, Delavar B, Motlagh ME. The burden of injuries in Iranian children in 2005. Popul Health Metr. 2010;8:5.
  • Centers for Disease Control and Prevention (CDC). Vital signs: prevalence, treatment, and control of hypertension – United States, 1999–2002 and 2005–2008. MMWR Morb Mortal Wkly Rep. 2011;60(4):103.
  • Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–2369.
  • Alireza Khosravi M, Reza Malekzadeh M, Sarrafzadegan N. Advocacy strategies and action plans for reducing salt intake in Iran. Arch Iran Med. 2012;15(5):320.
  • O’Flaherty M, Flores-Mateo G, Nnoaham K, Lloyd-Williams F, Capewell S. Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ. 2012;90(7):522–531.
  • Talaei M, Mohammadifard N, Khaje MR, et al. Healthy bread initiative: methods, findings, and theories – Isfahan Healthy Heart Program. J Health Popul Nutr. 2013;31(1):49.
  • Farahani M, Mohammadi E, Ahmadi F, Maleki M, Hajizadeh E. Cultural barriers in the education of cardiovascular disease patients in Iran. Int Nurs Rev. 2008;55(3):360–366.
  • Mohammadifard N, Sarrafzadegan N, Nouri F, et al. Using factor analysis to identify dietary patterns in Iranian adults: Isfahan Healthy Heart Program. Int J Public Health. 2012;57(1):235–241.
  • Alizadeh M, Mohtadinia J, Pourghasem-Gargari B, Esmaillzadeh A. Major dietary patterns among female adolescent girls of Talaat intelligent guidance school, Tabriz, Iran. Iran Red Crescent Med J. 2012;14(7):436.
  • Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr. 2007;137(4):992–998.
  • Khosravi-Boroujeni H, Sarrafzadegan N, Mohammadifard N, et al. White rice consumption and CVD risk factors among Iranian population. J Health Popul Nutr. 2013;31(2):252.
  • Dreon D, Fernstrom H, Miller B, Krauss R. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J. 1994;8(1):121–126.
  • Amani R. Obesity prevalence and its nutritional related lifestyle pattern in Jundi-Shapour University female staff, Ahvaz, Iran. Int J Endocrinol Metab. 2007;5(3):135–140.
  • Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr. 1999;70(3):439s–450s.
  • Esmaillzadeh A, Azadbakht L. Legume consumption is inversely associated with serum concentrations of adhesion molecules and inflammatory biomarkers among Iranian women. J Nutr. 2012;142(2):334–339.
  • Sajjadi F, Gharipour M, Mohammadifard N, Nouri F, Maghroun M, Alikhasi H. Relationship between legumes consumption and metabolic syndrome: findings of the Isfahan Healthy Heart Program. ARYA Atheroscler. 2014;10(1):18–24.
  • Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104(12):1336–1342.
  • Shurtleff W, Aoyagi A. History of Soybeans and Soyfoods in the Middle East: Extensively Annotated Bibliography and Sourcebook. Lafayette, CA: Soyinfo Center; 2008.
  • Ra A, Zand-Moghaddam A. Effects of soy protein isoflavones on serum lipids, lipoprotein profile and serum glucose of hypercholesterolemic rabbits. Int J Endocrinol Metab. 2005;2:87–92.
  • Keast DR, O’Neil CE, Jones JM. Dried fruit consumption is associated with improved diet quality and reduced obesity in US adults: National Health and Nutrition Examination Survey, 1999–2004. Nutr Res. 2011;31(6):460–467.
  • Moazen S, Amani R, Homayouni RA, Shahbazian H, Ahmadi K, Taha JM. Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: a randomized double-blind controlled trial. Ann Nutr Metab. 2012;63(3):256–264.
  • Amani R, Moazzen S, Shahbazian H, Ahmadi Ankali K, Homayouni Rad A, Jalali M. Effects of freeze-dried strawberries on lipid profile and glycated hemoglobin in subjects with type 2 diabetes: a double blind randomized control trial. Iran J Nutr Sci Food Tech. 2013;8(3):189–200.
  • Sedaqat F, Rabiei S, Faria S, Rastmanesh R. Correlates of snacking with stress and depression in obese and non-obese women. J Obes Weight Loss Ther. 2013;3(161):2.
  • Yazdekhasti N, Mohammadifard N, Sarrafzadegan N, Mozaffarian D, Nazem M, Taheri M. The relationship between nut consumption and blood pressure in an Iranian adult population: Isfahan Healthy Heart Program. Nutr Metab Cardiovasc Dis. 2013;23(10):929–936.
  • Askari G, Yazdekhasti N, Mohammadifard N, et al. The relationship between nut consumption and lipid profile among the Iranian adult population; Isfahan Healthy Heart Program. Eur J Clin Nutr. 2013;67(4):385–389.
  • Rodriguez-Casado A. The health potential of fruits and vegetables phytochemicals: notable examples. Crit Rev Food Sci Nutr. In Press 2014.
  • Berciano S, Ordovás JM. Nutrition and cardiovascular health. Rev Esp Cardiol. 2014;67(9):738–747.
  • Wightman JD, Heuberger RA. Effect of grape and other berries on cardiovascular health. J Sci Food Agric. In Press 2014.
  • American Heart Association Nutrition Committee; Lichtenstein AH, Appel LJ, et al. Diet and lifestyle recommendations revision 2006 A scientific statement from the American Heart Association nutrition committee. Circulation. 2006;114(1):82–96.
  • Sowers JR. Obesity as a cardiovascular risk factor. Am J Med. 2003;115(8):37–41.
  • Janghorbani M, Amini M, Willett WC, et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity. 2007;15(11):2797–2808.
  • Amani R. Comparison between bioelectrical impedance analysis and body mass index methods in determination of obesity prevalence in Ahvazi women. Eur J Clin Nutr. 2006;61(4):478–482.
  • Ba S, JC S, WPT J. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 2004;7(1a):123–146.
  • Amani R, Sharifi N. . Cardiovascular disease risk factors. In: Gaze D, editor. The Cardiovascular System-Physiology, Diagnostics and Clinical Implications. Rijeka: InTech; 2012:978–983.
  • Victora CG, Adair L, Fall C, et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet. 2008;371(9609):340–357.
  • Osmond C, Barker D. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect. 2000;108(Suppl 3):545.
  • Barker DJ. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition. 1997;13(9):807–813.
  • Sheikholeslam R, Naghavi M, Abdollahi Z, et al. Current status and the 10 years trend in the malnutrition indexes of children under 5 years in Iran. Iran J Epidemiol. 2008;4(1):21–28.
  • Jafari F, Eftekhar H, Pourreza A, Mousavi J. Socio-economic and medical determinants of low birth weight in Iran: 20 years after establishment of a primary healthcare network. Public Health. 2010;124(3):153–158.
  • Amani R. Assessment of the rate of low birthweight and its related factors in Ahvaz, Iran, in 1995 and 1996. Food Nutr Bull. 2000;21(3):290–292.
  • Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002;360(9331):473–482.
  • Kelishadi R, Ardalan G, Gheiratmand R, et al; Caspian Study Group. Thinness, overweight and obesity in a national sample of Iranian children and adolescents: CASPIAN Study. Child Care Health Dev. 2008;34(1):44–54.
  • Kelishadi R, Hashemi Pour M, Sarraf-Zadegan N, Ansari R, Alikhassy H, Bashardoust N. Obesity and associated modifiable environmental factors in Iranian adolescents: Isfahan Healthy Heart Program − heart health promotion from childhood. Pediatr Int. 2003;45(4):435–442.
  • Gordon-Larsen P, Nelson MC, Page P, Popkin BM. Inequality in the built environment underlies key health disparities in physical activity and obesity. Pediatrics. 2006;117(2):417–424.
  • Ebadi F, Saeednia E. . Food balance sheet of IR. In: Palooj M, editor. Iran 2001–2006: Overview of the Production and Distribution of Macronutrients and Micronutrients in Food. Tehran, Iran: Institute for Planning and Agricultural Economics; 2008.
  • Fakhrzadeh H, Ghotbi S, Pourebrahim R, et al. Total plasma homocysteine, folate, and vitamin b12 status in healthy Iranian adults: the Tehran homocysteine survey (2003–2004)/a cross-sectional population based study. BMC Public Health. 2006;6(1):29.
  • Strain J, Dowey L, Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc. 2004;63(4):597–604.
  • Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004;4(1):38.
  • Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan city, Iran. J Health Popul Nutr. 2011;29(2):149–155.
  • Neyestani TR, Hajifaraji M, Omidvar N, et al. High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr. 2012;15(2):324–330.
  • Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–511.
  • Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol. 2010;121(1):425–429.
  • Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28(5):1228–1230.
  • Riek AE, Oh J, Darwech I, Moynihan CE, Bruchas RR, Bernal-Mizrachi C. 25 (OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J Steroid Biochem Mol Biol. 2014; 144(pt A):172–179.
  • Heravifard S, Neyestani TR, Nikooyeh B, et al. Regular consumption of both vitamin D- and calcium- and vitamin D-fortified yogurt drink is equally accompanied by lowered blood lipoprotein (a) and elevated apoprotein A1 in subjects with type 2 diabetes: a randomized clinical trial. J Am Coll Nutr. 2013;32(1):26–30.
  • Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 2014;47(1):70–80.
  • Zittermann A. Vitamin D and cardiovascular disease. Anticancer Res. 2014;34(9):4641–4648.
  • Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009;63 (2):S5–S21.